ApprovalTrail

Approval · Notice of Compliance 3169 · 1998

NU-VALPROIC: Notice of Compliance 3169

Issued April 23, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
3169
Date
April 23, 1998
Company
Nu-Pharm IncVaughan, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Other
Therapeutic class
Anticonvulsant
Canadian reference product
DEPAKENE

Products in this notice

BrandDINStatus today
NU-VALPROIC02237830Approved

Medicinal ingredients